The good and the bad of T cell cross-reactivity: challenges and opportunities for novel therapeutics in autoimmunity and cancer

Gouttefangeas, Cecile; Klein, Reinhild; Maia, Ana

dc.contributor.author	Klein, Reinhild
dc.contributor.author	Maia, Ana
dc.contributor.author	Gouttefangeas, Cécile
dc.date.accessioned	2024-06-04T09:54:25Z
dc.date.available	2024-06-04T09:54:25Z
dc.date.issued	2023
dc.identifier.issn	1664-3224
dc.identifier.uri	http://hdl.handle.net/10900/154018
dc.language.iso	en	de_DE
dc.publisher	Lausanne : Frontiers Media Sa	de_DE
dc.relation.uri	http://dx.doi.org/10.3389/fimmu.2023.1212546	de_DE
dc.subject.ddc	570	de_DE
dc.subject.ddc	610	de_DE
dc.title	The good and the bad of T cell cross-reactivity: challenges and opportunities for novel therapeutics in autoimmunity and cancer	de_DE
dc.type	Article	de_DE
utue.quellen.id	20230928000000_00803
utue.personen.roh	Gouttefangeas, Cecile
utue.personen.roh	Klein, Reinhild
utue.personen.roh	Maia, Ana
dcterms.isPartOf.ZSTitelID	Frontiers in Immunology	de_DE
dcterms.isPartOf.ZS-Issue	Article 1212546	de_DE
dcterms.isPartOf.ZS-Volume	14	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE